Articles by Nicky Toor

Nicky graduated with a BA in Journalism and a Minor in English from Kwantlen Polytechnic University. She has written on a variety of different topics including fashion, beauty, entertainment and finance. Her favourite things to do are travel (when she can) and to spend time with friends and family, including her dog Kobe.

Neovasc Reducer Implanted in First US Patient

Jun 20 Nicky Toor

Shares of the Canadian medical devices company Neovasc Inc. (TSX:NVCN) (NASDAQ:NVCN) jumped over 20% today after the company announced that its first Neovasc Reducer for the treatment of refractory angina had been implanted into a US ... [Read]

Why Have Solid Biosciences Shares Risen Nearly 50%?

Jun 19 Nicky Toor

Solid Biosciences shares are up! Shares of the Massachusetts-based drug manufacturing company Solid Biosciences Inc. (NASDAQ:SLDB) rose nearly 50% after it was announced on Monday that the US Food and Drug Administration (FDA) had removed ... [Read]

ObsEva SA Reaches Clinical Trial Endpoint – Shares Jump +25%

Jun 18 Nicky Toor

The Swiss-based biotechnology company ObsEva SA (NASDAQ:OBSV) has announced that it has reached the endpoints of its clinical trial with shares jumping over 25% after the announcement was made. The company, which focuses on developing ... [Read]

Verastem Inc. Announces Stock Offering to Consonance Capital – Share Rise +15%

Jun 15 Nicky Toor

Massachusetts-based biopharmaceutical company Verastem Inc. (NASDAQ:VSTM) announced on Thursday that it would be offering approximately seven million shares of the company’s common stock to Consonance Capital (private). Shares of the company rose over 15% on ... [Read]

Hydropothecary Corp Greenhouse Expansion Approved, License Received!

Jun 14 Nicky Toor

Quebec-based medical cannabis company The Hydropothecary Corporations (TSXV:THCX) has finally received its phase one licensing for a 250,000-square-foot greenhouse expansion from Health Canada. The company has been preparing for the expansion for months and has more ... [Read]

WeedMD and Revive Therapeutics Enter Cannabis R&D Agreement

Jun 13 Nicky Toor

Ontario-based medical cannabis company WeedMD (TSX:WMD) has entered into an agreement with the biotechnology company Revive Therapeutics (TSX:RW). The announcement, which was released on Wednesday, has said that both companies will collaborate on the research ... [Read]

Isodiol International Acquires 51% of Round Mountain Technologies

Jun 12 Nicky Toor

Vancouver-based pharmaceutical company Isodiol International (CSE:ISOL) (OTC:ISOLF) has announced that it has entered into an agreement to purchase 51% of Round Mountain Technologies (RMT) LLC. Isodiol will purchase 52% interest in RMT for $250,000 USD in Isodiol stock and ... [Read]

Galmed Pharmaceuticals Shares Surge Nearly 150% After Phase 2B Study

Jun 12 Nicky Toor

Shares of the Israeli biotechnology company Galmed Pharmaceuticals Ltd. (NASDAQ:GLMD) surged nearly 150% on Tuesday after the company released its results on the Phase 2B ARREST study. The study was meant to focus on the ... [Read]

MPX Bioceutical Corp. Completes Acquisition of Canveda

Jun 11 Nicky Toor

The Toronto-based medical cannabis company MPX Bioceutical Corporation (CSE:MPX) announced that it had completed its acquisition of the medical cannabis company Canveda Inc., on Monday. MPX purchased Canveda for a total of $18.12 million CAD, with $3.12 million ... [Read]

Vical Inc. Reports Failed Phase 2 Trial of Herpes Vaccine

Jun 11 Nicky Toor

California-based biotechnology company Vical Incorporated (NASDAQ:VICL) released, on Monday, the results of its Phase 2 herpes simplex virus-2 (HSV-2) therapeutic vaccine. Unfortunately, the trial failed to meet its primary endpoint, so the company has decided ... [Read]